DME-Adjacent Medications on Pharmacy Lien: Wound Care, Surgical Prep, and More

James Wong — Founder & Pharmacist, LienScripts | March 29, 2026 | 8 min read

DME-adjacent medications — wound care supplies, surgical prep products, brace-related skin treatments, and ostomy care — are prescribed medications that fall between pharmacy and DME categories, often leaving PI patients without coverage. This guide explains pharmacy lien coverage for these overlooked treatment needs.

DME-adjacent medications are prescription and OTC-with-prescription products that support durable medical equipment use, wound healing, surgical preparation, and post-procedural care — categories of treatment that fall into a coverage gap between pharmacy benefits and DME benefits, leaving personal injury patients without access to products their physicians have determined are medically necessary. For PI attorneys, these overlooked medications represent both uncovered treatment costs and documentation opportunities, because their presence in the pharmacy record demonstrates the breadth of the patient's injury-related treatment needs beyond the obvious prescription medications.

• DME-adjacent medications include wound care products (silver sulfadiazine, collagenase, medical-grade honey dressings), surgical prep supplies (chlorhexidine wash, mupirocin nasal ointment for MRSA decolonization), brace-related skin care (barrier creams, antifungal powders), and ostomy supplies prescribed after traumatic abdominal injury
• These products are prescribed by the treating physician as part of the injury treatment plan but frequently fall outside insurance pharmacy benefit design, which covers traditional prescription medications, and outside DME benefits, which cover equipment but not the medications used with that equipment
• LienScripts covers DME-adjacent medications on pharmacy lien and documents them in the MERIT (Medication Evaluation & Rationale for Injury Treatment) report alongside standard prescription medications, creating a complete treatment record
• According to James Wong, PharmD, founder of LienScripts, "Patients tell us they were surprised that their insurance covered the wound VAC machine but not the wound care dressing, or the knee brace but not the skin cream to prevent breakdown underneath it — the pharmacy lien closes that gap"
• The FDA regulates many DME-adjacent products as drugs (silver sulfadiazine is a prescription medication) or medical devices (advanced wound dressings), and their clinical necessity is established by the prescribing physician's order

Categories of DME-Adjacent Medications

Wound Care Medications

PI patients with open wounds, surgical incisions, or skin grafts require specialized wound care products:

Silver sulfadiazine (Silvadene) — A prescription topical antimicrobial cream used for burn wounds and open skin injuries. FDA-approved and widely used in trauma care. Insurance may cover it during hospitalization but deny outpatient prescriptions.

Collagenase (Santyl) — An enzymatic debriding agent that removes necrotic tissue from wounds to promote healing. Prescription required. Often denied by insurance for outpatient use despite physician determination of medical necessity.

Medical-grade honey dressings (Medihoney, Manuka) — FDA-cleared wound care products with antimicrobial and healing properties. Classified as medical devices rather than drugs, which creates billing confusion between pharmacy and DME benefits.

Negative pressure wound therapy (wound VAC) supplies — The wound VAC device is typically covered as DME, but the dressings, canisters, and skin prep products used with it may not be covered under either pharmacy or DME benefits.

[!KEY] Wound care medications in the pharmacy record document ongoing wound management — evidence that the patient's injuries included tissue damage requiring prolonged healing. Each wound care prescription is a data point supporting the severity and duration of the injury's impact.

Surgical Preparation Products

Orthopedic and other surgeries in PI cases increasingly require pre-surgical medication protocols:

Chlorhexidine (Hibiclens) wash — Pre-surgical skin decontamination required before joint replacement, spinal surgery, and other implant procedures. Often prescribed for 3-5 days of twice-daily washing before surgery. While chlorhexidine wash is available OTC, the physician's prescription makes it a documented medical expense.

Mupirocin nasal ointment (Bactroban) — MRSA decolonization protocol before surgery. Many surgeons require patients to apply mupirocin to the nasal passages for 5 days before any implant surgery to reduce surgical site infection risk. This is a prescription medication with documented medical necessity.

Bowel prep medications — Required before abdominal or spinal surgeries. Typically prescription medications (GoLYTELY, MiraLAX prep kits) that insurance may not cover when prescribed for surgical preparation rather than colonoscopy.

Pre-surgical anxiety medications — Short-acting benzodiazepines or hydroxyzine prescribed for the night before and morning of surgery. These prescriptions document the psychological impact of injury-related surgical procedures.

Brace and Orthotic-Related Skin Care

PI patients wearing braces, splints, or orthotics for extended periods develop skin issues that require treatment:

Barrier creams and skin protectants — Prescription-strength barrier creams (dimethicone-based, zinc oxide formulations) prevent skin maceration and breakdown under braces and casts.

Antifungal treatments — Extended brace or cast wear creates warm, moist environments that promote fungal skin infections. Prescription antifungals (ketoconazole cream, nystatin powder) treat these secondary complications.

Skin repair products — Products to treat skin breakdown, pressure sores, or contact dermatitis caused by prolonged DME use. These are secondary injuries caused by the treatment of the primary injury.

[!TIP] Brace-related skin complications are additional damages caused by the treatment of the original injury. Document these secondary complications and their treatments in the demand package — they extend the injury narrative beyond the primary trauma and demonstrate the cascading consequences of the defendant's actions.

Post-Surgical and Post-Procedural Care

Scar management products — Silicone-based scar sheets and gels (ScarAway, Mederma) prescribed after surgical closure. While some are available OTC, physician-prescribed scar management is a medical expense attributable to the injury.

Topical anesthetics for procedure preparation — Lidocaine cream or EMLA cream prescribed before injections, nerve blocks, or other procedures. Each prescription documents an additional medical intervention.

Stoma and ostomy care supplies — Traumatic abdominal injuries requiring ostomy creation generate ongoing supply needs (barrier rings, skin prep wipes, ostomy powder) that may fall between pharmacy and DME coverage.

As Amar Lunagaria, PharmD, LienScripts' Chief Pharmacist explains, "The pharmacy lien is designed to cover everything the physician prescribes for injury treatment. We do not draw an artificial line between 'real medications' and wound care or surgical prep. If the doctor prescribed it for the injury, the lien covers it, and the MERIT report documents it."

Why These Products Fall Through Insurance Gaps

The insurance coverage gap for DME-adjacent medications exists because of benefit design silos:

1. Pharmacy benefits cover prescription medications dispensed by pharmacies — but wound dressings, surgical prep products, and skin care items may not have pharmacy NDC codes
2. DME benefits cover equipment (braces, wound VACs, wheelchairs) — but not the medications and supplies used with that equipment
3. Medical benefits cover in-office procedures and supplies — but not the same products when used at home
4. OTC exclusions — even when a physician prescribes an OTC product as medically necessary, many plans exclude OTC items from coverage

The result: the patient's physician has prescribed specific products for injury treatment, but no insurance benefit category covers them. The patient is left to pay out of pocket or go without — both unacceptable outcomes during PI treatment.

Settlement Documentation Value

DME-adjacent medications add to the demand package in several ways:

Treatment breadth — The pharmacy record showing wound care products, surgical prep medications, brace-related treatments, and standard prescriptions documents the full scope of injury-related treatment needs. This breadth communicates severity more effectively than prescription medications alone.

Duration evidence — Wound care products dispensed over weeks or months document ongoing healing. Brace-related skin treatments document prolonged DME use. Each fill is a timestamp of continuing treatment.

Secondary complication documentation — Skin breakdown under a brace, surgical site infection requiring additional antibiotics, wound healing complications requiring collagenase — these secondary complications are additional damages caused by the treatment of the primary injury.

Completeness — A demand package that includes DME-adjacent medications demonstrates thorough damage documentation. It shows the attorney has captured the full scope of treatment costs, not just the obvious prescription medications.

[!KEY] DME-adjacent medications are frequently overlooked in demand packages because they do not fit neatly into the "prescription medication" category. Including them demonstrates thorough damage documentation and adds treatment breadth that communicates injury severity. The MERIT report from LienScripts captures these items alongside standard medications.

Pharmacy Lien Coverage

LienScripts covers DME-adjacent medications on pharmacy lien when prescribed by the treating physician for injury-related treatment. This includes:

• Prescription wound care medications (silver sulfadiazine, collagenase)
• Physician-prescribed surgical preparation products
• Prescription skin care treatments for brace-related complications
• Post-surgical scar management and care products
• Ostomy supplies and related medications

The pharmacy lien ensures the patient receives every prescribed product without navigating the insurance coverage gap between pharmacy, DME, and medical benefits.

FAQs

Related Resources

• Compound Medication Customization on Pharmacy Lien
• Burn Injury Medication Management: Pharmacy Lien Guide
• What Is a Pharmacy Lien?
• What Is a MERIT Report?